These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9182144)

  • 1. [Evaluation of the usefulness of the peripheral test for determination of rabies vaccine potency].
    Wysokińska T; Janaszek W; Rymkiewicz D; Słowikowska M
    Med Dosw Mikrobiol; 1996; 48(3-4):211-3. PubMed ID: 9182144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the usefulness of the antibody binding test for the estimation of the potency of the rabies vaccine].
    Wysokińska T; Janaszek W; Rymkiewicz D
    Przegl Epidemiol; 1994; 48(3):297-9. PubMed ID: 7938635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory techniques in rabies. Potency-test requirements of the United States National Institutes of Health (NIH).
    Seligmann EB
    Monogr Ser World Health Organ; 1966; 23():145-51. PubMed ID: 4960445
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies vaccine standards: comparison of the 5th and 6th WHO international reference standards to the USDA veterinary reference standard.
    Hermann J; Fry A; Reising M; Patterson P; Siev D; Gatewood D
    Vaccine; 2012 Nov; 30(48):6892-6. PubMed ID: 22981761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies vaccines for veterinary use: difficulties in establishing potency acceptability thresholds.
    Aubert M
    Dev Biol Stand; 1992; 79():113-20. PubMed ID: 1286746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of Immediate Introduction of a Single-Dose Antibody Induction Test as a Refinement of the NIH Test for Inactivated Rabies Vaccine Potency Determination.
    Stankov S; Obradović N; Vujin D; Vranješ N
    Viral Immunol; 2020 Jun; 33(5):367-377. PubMed ID: 32159457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New standard for rabies vaccines?
    Young O
    Lab Anim (NY); 2007 Jan; 36(1):8. PubMed ID: 17183326
    [No Abstract]   [Full Text] [Related]  

  • 16. Rabies deaths in Pakistan: results of ineffective post-exposure treatment.
    Parviz S; Chotani R; McCormick J; Fisher-Hoch S; Luby S
    Int J Infect Dis; 2004 Nov; 8(6):346-52. PubMed ID: 15494256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and pre-validation of a quantitative multi-dose serological assay for potency testing of inactivated rabies vaccines for human use.
    Moreira WC; Freitas JFS; Machado NS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Jan; 263():54-59. PubMed ID: 30393149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution.
    de Moura WC; de Araujo HP; Cabello PH; Romijn PC; Leite JP
    J Virol Methods; 2009 Jun; 158(1-2):84-92. PubMed ID: 19428574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NIH potency tests with inactivated rabies vaccines (author's transl)].
    Barth R; Jaeger O
    Zentralbl Bakteriol B; 1979; 169(5-6):488-94. PubMed ID: 545949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.